Combined with the observation that APOB is mutated in about 10% of human HCC and that APOB mutation is associated with decreased survival probability in HCC (Fig. 2e), this finding highlights a tumor suppressive function of APOB in HCC. Here, APOB is linked to hepatocellular carcinoma.